Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250757 · ClinicalTrials.gov registry record
Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions
A clinical trial, sponsored by New Mexico Cancer Research Alliance.
- Terminated
- Registry status
- 101
- Enrollment target
NCT00250757: Clinical Trial study, sponsored by New Mexico Cancer Research Alliance.
NCT00250757 is a clinical trial that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00250757 was terminated before completion, sponsored by New Mexico Cancer Research Alliance.
- TERMINATED
- Registry status
- 101 participants
- Enrollment target
Study Summary
To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-10 |
| Est. Completion | 2012-04 |
Why NCT00250757 stopped before completion
NCT00250757 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00250757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00250757 about?
NCT00250757 is a clinical study titled "Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions". To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.
What is the current status of trial NCT00250757?
This trial is currently terminated. The enrollment target is 101 participants. The study started on 2005-10. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT00250757?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia